<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Routine meningococcal vaccination recommendations for healthy adolescents and young adults age 11 through 23 years in the United States&lt;sup&gt;[1-3]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Routine meningococcal vaccination recommendations for healthy adolescents and young adults age 11 through 23 years in the United States<sup>[1-3]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Routine meningococcal vaccination recommendations for healthy adolescents and young adults age 11 through 23 years in the United States<sup>[1-3]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="25%"></colgroup> <colgroup width="50%"></colgroup> <tbody> <tr> <td class="subtitle1">Meningococcal vaccine</td> <td class="subtitle1">Primary dose(s)</td> <td class="subtitle1">Booster dose(s)</td> </tr> <tr> <td> MenACWY<br/> (for those age 11 through 21 years)*</td> <td> MenACWY (any licensed vaccine): <ul class="decimal_heading"> <li>1 dose, at age 11 through 18 years; preferred age: 11 through 12 years</li> </ul> </td> <td> MenACWY (any licensed vaccine): <ul class="decimal_heading"> <li>1 dose at age ≥16 years; the minimum interval between doses is 8 weeks.<sup>¶</sup></li> <li style="list-style-type: none;">If first dose given after age 16 years, then booster is not needed unless the person is at increased risk for meningococcal disease.</li> <li>College freshmen living in residence halls should receive ≥1 dose of MenACWY ≤5 years before college entry.</li> </ul> </td> </tr> <tr> <td> MenB<br/> (for those age 16 through 23 years based on shared decision-making)<sup>Δ</sup></td> <td> Preferred age: 16 through 18 years <p class="extra_spacing_top">Either:</p> <ul class="decimal_heading"> <li>MenB-4C: 2 doses, ≥1 month apart</li> <li style="list-style-type: none;"><strong>or</strong></li> <li>MenB-FHbp: 2 doses, ≥6 months apart</li> </ul> </td> <td>Not routinely recommended unless the person becomes at risk (eg, exposed during an outbreak, occupational risk).</td> </tr> </tbody></table></div><div class="graphic_lgnd">This table is meant for use with UpToDate content on meningococcal vaccination. Refer to UpToDate content for additional details, including meningococcal vaccination of persons at increased risk of meningococcal disease and details of shared decision-making.
    <ul>
<li>Two MenACWY are licensed in the United States:
            <ul>
<li>MenACWY-CRM (Menveo)</li>
<li>MenACWY-TT (MenQuadfi)</li>
</ul>
</li>
<li style="list-style-type: none;">MenACWY-D (Menactra) was discontinued in 2022.</li>
<li style="list-style-type: none;">Although each of the MenACWY vaccine formulations use a different protein conjugate, the products are considered interchangeable in persons ≥2 years of age. The same vaccine product is recommended, but not required, for all doses.</li>
<li>Two MenB vaccines are licensed in the United States:
        <ul class="decimal_heading">
<li>MenB-4C (Bexsero)</li>
<li>MenB-FHbp (Trumenba)</li>
</ul>
</li>
<li style="list-style-type: none;"><strong>MenB vaccines are not interchangeable</strong>; the same brand must be used for each dose of the primary series and all booster doses (if indicated).</li>
</ul></div><div class="graphic_footnotes"><p>MenACWY: meningococcal groups A, C, W, and Y conjugate vaccine; MenB: serogroup B meningococcal vaccine; ACIP: Advisory Committee on Immunization Practices.</p>
<p>* Although the ACIP recommends routine MenACWY vaccination only for adolescents age 11 through 18 years, MenACWY may be given to persons age 19 through 21 years who have not received a dose.</p>
<p>¶ For unvaccinated adolescents and young adults with an underlying condition for which a 2-dose primary series of MenACWY vaccination is recommended, the second dose should be given as soon after the 8-week minimum interval as possible.</p>
    
    Δ Given the seriousness of meningococcal disease and efficacy and safety of available formulations, we suggest MenB for persons age 16 through 23 years.</div><div class="graphic_reference">References:
    <ol>
<li>Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep 2020; 69:1.</li>
<li>Immunization Action Coalition. Meningococcal ACWY vaccine recommendations by age and risk factor. <a href="https://www.immunize.org/catg.d/p2018.pdf" target="_blank">https://www.immunize.org/catg.d/p2018.pdf</a> (Accessed on October 26, 2020).</li>
<li>Immunization Action Coalition. Meningococcal B vaccine recommendations by age and risk factor. <a href="https://www.immunize.org/catg.d/p2035.pdf" target="_blank">https://www.immunize.org/catg.d/p2035.pdf</a> (Accessed on October 26, 2020).</li>
</ol></div><div id="graphicVersion">Graphic 130148 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
